Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-25 @ 4:27 AM
NCT ID:
NCT02809820
Eligibility Criteria:
Inclusion Criteria:
* Acute Coronary Syndrome
* Current dual anti platelet treatment with acetylsalicylic acid and Ticagrelor
Exclusion Criteria:
* ongoing prasugrel, ticlopidine or clopidogrel therapy
* Creatinine Clearance \< 30 ml/min/1.73mm2
* Moderate to severe anemia Hemoglobin \< 10 mg/dl
* Platelet count \>600000/mm3 or \<150000/mm3 or hematocrit \>50% or \<25%
* concomitant neoplastic or immune-mediated pathologies
* severe pulmonary pathologies
* contraindication to beta blocker therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT02809820
Study Brief:
Protocol Section:
NCT02809820